Our Company
N2MO is operating in the early drug discovery environment where our offerings ensure the research companies faster, cheaper and more flexible processes to detect compounds for further processing towards final drug development.
Through close collaboration with academia in Europe as well as with biotech and big pharma companies we have developed and fine tuned the models so they accommodate the need for science and for commercial drug discovery.
The data have been published in peer reviewed magazines and now we are ready to commercialize the services in large scale.
As CRO service we offer our fully validated ex vivo screening models providing an exciting opportunity to make customized study design generating more sophisticated and completely unique data to assess:
- Barrier permeability that discriminates CNS from non-CNS compounds.
- Concentration dependent brain uptake patterns.
- Identification and classification of Pgp transporter substrates.
- Identification of energy dependent substrate transport.
- Quantification of BBB permeability.
- Pgp substrates that may have terapeutic effect on CNS target.
- Transporter substrates (Influx / efflux).
- Slow vs fast permeating compounds.
Management
With his technical and commercial background Preben has spend almost his whole career in…
With his technical and commercial background Preben has spend almost his whole career in international business with growing responsibilities from sales to general management, and with temporary assignments in France, The UK and the US.
Björn has more than 20 years experience within the Life Science sector…
Björn has more than 20 years of experience from different aspects in the Life Science sector. He has been working in academia as associate professor, in the pharmaceutical industry, in strategic consulting and government affairs. Björn has a very broad international network and is known for being able to see new solutions to challenges.Board of Director
With Karin’s medical and commercial background Karin has spend almost her whole career in international business…
With her medical and commercial background Karin has spend almost her whole career in international business with growing responsibilities from sales to general management primarily in big American pharmaceutical companies.
Erik brings along 25 years of international General Management, Board and …
Erik brings along 25 years of international General Management, Board and Consulting experience in Europe and Asia, via leading production and service companies.
With his scientific back ground Klaus has devoted his career to drug discovery…
With his scientific back ground Klaus has devoted his career to drug discovery in both academia, biotech and pharma with growing responsibility from specialist via project leadership to scientific management and is currently VP and Global Head of Discovery Chemistry at Lundbeck.
Martin is the CFO at Retap and has been working in the financial sector for more than 20 years…
Michael is partner at the law firm Rønne & Lundgren and renowned as one of the leading…
Michael is partner at the law firm Rønne & Lundgren and renowned as one of the leading company lawyers in Denmark.
With his technical and commercial background Preben has spend almost his whole career in…